Enliven Therapeutics, Inc. ($ELVN)
Hohl Benjamin โ CHIEF FINANCIAL OFFICER
Shares
10,000
Price
$29.58
Total Value
$295,839.00
Nearby Earnings
Mar 12, 2026
EPS:Est: -0.42
Transaction Details
| Insider | Hohl Benjamin |
|---|---|
| Title | CHIEF FINANCIAL OFFICER |
| Transaction Date | Mar 6, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 10, 2026 |
| Shares Sold | 10,000 |
| Price per Share | $29.58 |
| Total Value | $295,839.00 |
| Shares Owned After | 51,000 |
| Derivative | No |
| Accession Number | 0001882764-26-000002 |
| Document | View SEC Filing |